APA (7th ed.) Citation

JA, M., KA, F., A, A., J, N., G, R., SL, H., . . . WN, E. (2016). Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms. Journal of clinical pathology, 69(2), 155. https://doi.org/10.1136/jclinpath-2015-203177

Chicago Style (17th ed.) Citation

JA, Malherbe, et al. "Megakaryocytic Hyperplasia in Myeloproliferative Neoplasms Is Driven by Disordered Proliferative, Apoptotic and Epigenetic Mechanisms." Journal of Clinical Pathology 69, no. 2 (2016): 155. https://doi.org/10.1136/jclinpath-2015-203177.

MLA (9th ed.) Citation

JA, Malherbe, et al. "Megakaryocytic Hyperplasia in Myeloproliferative Neoplasms Is Driven by Disordered Proliferative, Apoptotic and Epigenetic Mechanisms." Journal of Clinical Pathology, vol. 69, no. 2, 2016, p. 155, https://doi.org/10.1136/jclinpath-2015-203177.